ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat

Shares of ResMed dropped about 6% in morning trade on Friday after the medtech company forecast fiscal 2027 revenue below Wall ​Street expectations, impacted by suspended ventilator sales and cost pre...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。